or Try an Advanced Search...

    Technical Analysis for PTCT - PTC Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 37.56 -0.27% -0.10
    PTCT closed down 0.27 percent on Friday, September 27, 2024, on 1.96 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical PTCT trend table...
    Date Alert Name Type % Chg
    Inside Day Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Pocket Pivot Bullish Swing Setup -0.27%
    Overbought Stochastic Strength -0.27%
    Upper Bollinger Band Touch Strength -0.27%
    Stochastic Sell Signal Bearish 2.51%
    Overbought Stochastic Strength 2.51%
    Narrow Range Bar Range Contraction 2.85%
    Overbought Stochastic Strength 2.85%
    Older End-of-Day Signals for PTCT ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 12 hours ago
    1.5x Volume Pace about 13 hours ago
    Down 1% about 15 hours ago
    Reversed from Up about 16 hours ago
    Gap Up Closed about 16 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PTCT Chart by TradingView
    Basic chart:

    Profile

    PTC Therapeutics, Inc. Description

    PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Biology Infectious Diseases Neurological Disorders Gene Expression Dystrophy Muscular Dystrophy Cystic Fibrosis Neurodegenerative Disorders Transcription Spinal Muscular Atrophy Genzyme Neuromuscular Disorders

    Is PTCT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 26 PTC Therapeutics Huntington's disease candidate nabs FDA Fast Track status
    Sep 26 FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
    Sep 12 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Sep 12 PTC Therapeutics: Positive HD Data Along With NDA Submission Brings Further Value
    Aug 28 PTC Therapeutics to Participate at Upcoming Investor Conferences
    Aug 26 PTC Therapeutics Has Upside Potential With Multiple Upcoming Catalysts, UBS Says
    Aug 26 PTC Therapeutics rises as UBS restarts coverage with buy rating
    Aug 19 PTC Therapeutics Stock Earns RS Rating Upgrade To 83
    Aug 10 PTC Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Aug 9 PTC Therapeutics, Inc. (PTCT) Q2 2024 Earnings Call Transcript
    See more PTCT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 40.69
    52 Week Low 17.53
    Average Volume 552,515
    200-Day Moving Average 31.09
    50-Day Moving Average 33.72
    20-Day Moving Average 34.48
    10-Day Moving Average 36.23
    Average True Range 1.44
    RSI (14) 69.33
    ADX 21.25
    +DI 28.82
    -DI 13.47
    Chandelier Exit (Long, 3 ATRs) 34.31
    Chandelier Exit (Short, 3 ATRs) 34.72
    Upper Bollinger Bands 38.70
    Lower Bollinger Band 30.27
    Percent B (%b) 0.87
    BandWidth 24.43
    MACD Line 1.06
    MACD Signal Line 0.68
    MACD Histogram 0.3803
    Fundamentals Value
    Market Cap 2.83 Billion
    Num Shares 75.5 Million
    EPS -8.82
    Price-to-Earnings (P/E) Ratio -4.26
    Price-to-Sales 2.45
    Price-to-Book 1743.27
    PEG Ratio 0.81
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 38.81
    Resistance 3 (R3) 38.83 38.45 38.60
    Resistance 2 (R2) 38.45 38.13 38.43 38.53
    Resistance 1 (R1) 38.00 37.93 37.81 37.98 38.46
    Pivot Point 37.62 37.62 37.52 37.60 37.62
    Support 1 (S1) 37.17 37.30 36.98 37.15 36.66
    Support 2 (S2) 36.79 37.10 36.77 36.59
    Support 3 (S3) 36.34 36.79 36.52
    Support 4 (S4) 36.32